Related Experiment Video
Updated: May 27, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Schizophrenia: medical illness, mortality, and aging
David A Casey1, Mercedes Rodriguez, Colleen Northcott
1Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY 40202, USA. david.casey@louisville.edu
International Journal of Psychiatry in Medicine
|November 12, 2011
Summary
Schizophrenia significantly impacts physical health and lifespan, often leading to serious medical conditions like diabetes and heart disease. Improved coordination between psychiatric and primary care is crucial for better patient outcomes.
Area of Science:
- Psychiatry
- Gerontology
- Public Health
Background:
- Schizophrenia is a common psychiatric disorder with significant medical comorbidities.
- Individuals with schizophrenia experience reduced life expectancy and increased medical morbidity.
- Aging in schizophrenia presents unique challenges for healthcare.
Purpose of the Study:
- To discuss medical problems associated with schizophrenia in aging individuals.
- To highlight the underestimation of schizophrenia's impact on physical health and aging.
- To emphasize the need for integrated care approaches.
Main Methods:
- Literature review of recent studies.
- Databases searched include Pubmed, Medline, and Google Scholar.
- Keywords used: "schizophrenia, aging, medical problems."
Main Results:
- Schizophrenia is linked to substantial medical morbidity and mortality.
- Diabetes, cardiovascular disease, smoking, and obesity are prevalent in schizophrenia patients.
- These conditions contribute to diminished quality of life and shorter lifespans, often due to inadequate medical care.
Conclusions:
- The physical health impacts of schizophrenia on aging are underestimated.
- Psychiatrists and primary care physicians must address both medical and psychiatric aspects.
- Enhanced coordination within the medical care system is essential for schizophrenia patients.
Related Concept Videos
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...